Companies /Financial Services

SLR Investment Corp

NASDAQ: SLRC Asset Management
$12.52
â–² $0.04 (+0.32%) today
Markets closed · 8:01pm ET

Q4 2025 Earnings

Reported Feb 24, 2026, 4:45pm ET · SEC source
$0.40
Miss −0.10%
EPS · est. $0.40
$54.5M
Miss −0.93%
Revenue · est. $55.0M
+0.4%
Beating market
SLRC vs S&P since report
6 quarters
Consecutive EPS misses

Market Reaction

% change · around the report
−2%0+2%Feb 24Feb 25report 4:45pm ETearnings+0.8%+3.4%
−2%0+2%Feb 24Feb 25earnings+0.8%+3.4%
SLRC +3.4%S&P 500 +0.8%
−2%0+2%Feb 24Feb 25report 4:45pm ETearnings+1.4%+3.4%
−2%0+2%Feb 24Feb 25earnings+1.4%+3.4%
SLRC +3.4%NASDAQ +1.4%
−2%0+2%+4%Feb 23Mar 4report 4:45pm ETearnings−0.3%+0.8%
−2%0+2%+4%Feb 23Mar 4earnings−0.3%+0.8%
SLRC +0.8%S&P 500 −0.3%
−2%0+2%+4%Feb 23Mar 4report 4:45pm ETearnings+0.5%+0.8%
−2%0+2%+4%Feb 23Mar 4earnings+0.5%+0.8%
SLRC +0.8%NASDAQ +0.5%
+3.34%
Day of report
+0.13%
Next session
−2.58%
One week
−8.12%
30 days

S&P 500 over the same 30 days: −8.52%.

Did SLRC Beat Earnings? Q4 2025 Results

SLR Investment Corp. delivered a largely in-line but slightly soft fourth quarter for fiscal 2025, with net investment income of $0.40 per share falling just 0.10% short of the $0.40 consensus estimate, while reported revenue of $54.46 million trailed analyst expectations by a wide margin, though the year-over-year revenue gain of 33.8% underscored the firm's longer-term growth trajectory. The modest shortfall was principally tied to a smaller average income-producing portfolio and lower index rates throughout the year, dynamics that also pushed full-year net investment income to $1.59 per share from $1.77 per share in fiscal 2024. On the credit quality front, the picture remained exceptionally clean, with the $3.30 billion Comprehensive Investment Portfolio sitting at 100% performing and carrying virtually no non-accrual exposure, a distinction management pointed to amid broader industry scrutiny over private credit's software sector concentrations. With over $850 million in available capital and a leverage ratio of 1.14x net debt-to-equity, management signaled it is positioned to deploy capital opportunistically in 2026, continuing its deliberate pivot toward direct asset-based lending backed by high-quality current assets.

Key Takeaways
  • Stability in both NII and NAV per share generating 10.1% return on equity
  • Shift to direct asset-based lending investments supported by high-quality current assets as collateral
  • 100% performing portfolio with no investments on non-accrual
  • Diversification across approximately 880 issuers in 110 industries
  • 97.8% of Comprehensive Investment Portfolio in senior secured loans
  • Only ~2% exposure to software companies
  • Payment-in-kind from amendments represented only ~2% of total Q4 investment income

“SLRC's fourth-quarter results solidified a strong year for the Company despite challenging conditions in the private credit industry. The stability in both NII and NAV per share in the fourth quarter generated a 10.1% return on equity and showcased another quarter of broad resilience in our portfolio, steady portfolio growth, and a continuation of a shift to direct asset based-lending investments that are supported primarily by high quality current assets as collateral and an expectation for attractive risk-adjusted returns.”

SLR Investment CEO, on the earnings call

Forward Guidance & Outlook

Management indicated that SLRC's stable portfolio and available capital (over $850 million in aggregate) positions the company to be active and opportunistic in 2026. The company continues its deliberate shift toward direct asset-based lending investments supported by high-quality current assets as collateral, with expectations of attractive risk-adjusted returns.

SLRC YoY Financials

Q4 2025 vs Q4 2024 · SEC filings Q4 2024 Q4 2025
$0$20.0M$40.0M$40.7M$54.5MRevenue$22.6M$25.1MNet Income
$0$20.0M$40.0MRevenueNet Income

SLRC Revenue by Segment

Asset-Based Lending$26.0M
Equipment Financings
Sponsor Finance (Cash Flow Loans)
Life Science Loans
Asset-based Lending
Sponsor Finance$11.7M
Equipment Finance$7.9M
Life Science Finance$8.9M

Figures from SEC filings and company reports. Not investment advice.